CN113058140A - Dosage control system of medicine delivery pump body and corresponding terminal - Google Patents
Dosage control system of medicine delivery pump body and corresponding terminal Download PDFInfo
- Publication number
- CN113058140A CN113058140A CN202010641079.1A CN202010641079A CN113058140A CN 113058140 A CN113058140 A CN 113058140A CN 202010641079 A CN202010641079 A CN 202010641079A CN 113058140 A CN113058140 A CN 113058140A
- Authority
- CN
- China
- Prior art keywords
- uterus
- drug delivery
- equipment
- delivery pump
- pump body
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/43—Detecting, measuring or recording for evaluating the reproductive systems
- A61B5/4306—Detecting, measuring or recording for evaluating the reproductive systems for evaluating the female reproductive systems, e.g. gynaecological evaluations
- A61B5/4318—Evaluation of the lower reproductive system
- A61B5/4325—Evaluation of the lower reproductive system of the uterine cavities, e.g. uterus, fallopian tubes, ovaries
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
The invention relates to a dosage control system of a medicine delivery pump body and a corresponding terminal, wherein the system comprises: a drug delivery pump body connected to the volume estimation device for receiving a real-time volume of the uterus and determining a drug delivery dose proportional to the real-time volume to perform a drug delivery of the determined drug delivery dose to the interior of the uterus; the panoramic capture mechanism is arranged in the uterus of the human body and is used for performing instant image capture on the internal environment of the uterus so as to obtain a corresponding uterus panoramic image; and the guide filtering equipment is connected with the panoramic capturing mechanism and is used for executing guide filtering processing on the received image. The dosage control system of the medicine delivery pump body and the corresponding terminal are simple to operate and stable to operate. Because can realize the real-time measurement to the uterus volume of different human different moments to dose based on measurement result decision current confession medicine, thereby when promoting the utilization ratio of uterus treatment medicine, realize the suitable confession medicine to the uterus.
Description
Technical Field
The invention relates to the field of uterus medicine supply, in particular to a medicine delivery pump body dosage control system and a corresponding terminal.
Background
The uterus is the organ that produces the menses and gestates the fetus, is located in the center of the pelvic cavity, between the bladder and the rectum. The uterus size is related to age and fertility, and the undelivered one is about 7.5cm long, 5cm wide and 3cm thick, and the uterus can be divided into three parts, namely, the base, the body and the neck. The uterine cavity is in an inverted triangle shape, the depth is about 6cm, and two upper corners are uterine horns and lead to the oviduct. The lower end is narrow and is an isthmus part, and the length is about 1 cm. The isthmus gradually expands during pregnancy, forming the lower uterine segment in labor.
The ratio of uterus to cervix varies with age, and the infant stage is 1: 2, puberty is 1: 1, the growth period is 2: 1. The uterus normally bends slightly forward, with the anterior wall lying prone on the bladder, at almost right angles to the vagina, and the position can vary with the degree of rectal filling of the bladder. The uterine wall is divided into three layers, namely serous membrane, muscular layer and mucosa (namely intima) from outside to inside.
The endometrium, i.e. the mucosa, consists of epithelium (a single-layer columnar epithelium with both secretory cells and ciliated cells) and (a connective tissue with a large number of astrocytes, called stromal cells), the endometrium is divided into superficial functional membranes and deep basal layers, the functional layer is thicker, about 4/5, the basal layer is thinner and denser, about 1/5, the functional layer can be exfoliated during the menstrual cycle, while the basal layer cannot be exfoliated.
Currently, due to the special structure of the uterus, the uterus is difficult to supply medicine, and the self-adaptive medicine supply strategy is not necessarily established according to the body conditions of different people.
Disclosure of Invention
In order to solve the related technical problems in the prior art, the invention provides a drug delivery pump body dose control system which can realize real-time measurement of uterine volumes of different human bodies at different moments to determine the current drug delivery dose based on the measurement result, so that the utilization rate of uterine treatment drugs is improved, and proper drug delivery to the uterus is realized.
Therefore, the invention needs to have the following key invention points:
(1) in view of different uterine volumes of different human bodies and the change of the uterine volumes of the same human body at different moments, a self-adaptive medicine supply dosage decision mechanism based on a uterine volume detection result is adopted, so that the uterus of the current human body can obtain the medicine with the dosage matched with the actual volume of the uterus;
(2) and estimating the current real-time volume of the human body uterus based on the real-time distance between the real position of each uterus inner wall entity and the panoramic capturing mechanism, which is identified with high precision.
According to an aspect of the present invention, there is provided a drug delivery pump body dose control system, the system comprising:
a drug delivery pump body connected to the volume estimation device for receiving a real-time volume of the uterus and determining a drug delivery dose proportional to the real-time volume to perform a drug delivery of the determined drug delivery dose to the interior of the uterus;
the panoramic capture mechanism is arranged in the uterus of the human body and is used for performing instant image capture on the internal environment of the uterus so as to obtain a corresponding uterus panoramic image;
the guide filtering equipment is connected with the panoramic capturing mechanism and used for executing guide filtering processing on the received image so as to obtain and output a corresponding guide filtering image;
the smooth spatial filtering equipment is connected with the guide filtering equipment and is used for executing smooth spatial filtering processing on the received guide filtering image so as to obtain and output a corresponding smooth spatial filtering image;
the gamma correction device is connected with the smooth space filtering device and is used for executing gamma correction processing on the received smooth space filtering image so as to obtain and output a corresponding gamma correction image;
the uterine body analysis device is connected with the gamma correction device and is used for detecting the pixel value of each pixel of the gamma correction image to determine whether the pixel value is in the brightness threshold range of the distribution of imaging pixel points on the inner wall of the uterus or not, and if the pixel value is in the brightness threshold range, the pixel is determined as a uterine body pixel and the imaging depth of field of the pixel is detected;
the volume estimation device is connected with the uterine body analysis device and is used for calculating the real-time distance between the intrauterine wall entity position corresponding to each uterine body pixel and the panoramic capturing mechanism based on the imaging depth of field of each uterine body pixel of the gamma correction image and the imaging focal length of the panoramic capturing mechanism;
the volume estimation equipment is further used for estimating the real-time volume of the uterus based on the real-time distance between the entity position of each uterine inner wall corresponding to each uterine body pixel of the gamma correction image and the panoramic capture mechanism.
According to another aspect of the present invention, there is also provided a terminal for controlling dosage of a drug delivery pump body, the terminal comprising: a memory and a processor, the processor coupled to the memory; the memory for storing executable instructions of the processor; the processor is used for calling the executable instructions in the memory so as to realize the method for determining the drug supply dosage of each uterus based on the real-time volume conditions of different human uteruses by using the drug delivery pump body dosage control system to ensure the corresponding treatment effect.
The dosage control system of the medicine delivery pump body and the corresponding terminal are simple to operate and stable to operate. Because can realize the real-time measurement to the uterus volume of different human different moments to dose based on measurement result decision current confession medicine, thereby when promoting the utilization ratio of uterus treatment medicine, realize the suitable confession medicine to the uterus.
Detailed Description
Embodiments of the present invention of the drug delivery pump body dosage control system and corresponding terminal will be described in detail below.
The uterus is located in the middle of the pelvic cavity, between the bladder and the rectum. The position may vary depending on the degree or position of bladder and rectum filling. When the uterus is upright, the uterus is almost parallel to the horizontal plane, the uterus bottom is laid over the back of the bladder, and the cervix is kept above the plane of the ischial spine. The normal uterus of an adult is in a slightly anteverted and anteverted posture, the anteverted uterus is an angle which is opened forwards between the uterine axis and the vaginal axis, and the anteverted uterus is a curve between the uterine body and the cervix. The normal position of the uterus is mainly maintained by structures such as ligaments of the uterus, pelvic diaphragm, urogenital diaphragm, central tendon of perineum and the like, and when the structures are damaged or loosened, the uterine prolapse can be caused.
The uterus can be divided into four parts of a bottom, a body, an isthmus and a neck, the upper end of the uterus is in a blunt round bulge, and the part above the uterine orifices of the two fallopian tubes is the bottom; the narrow, thin and cylindrical part of the lower segment is the neck, which is the site of inflammation and cancer, and the cervix is divided into the upper part of the vagina and the vaginal part. The part between the bottom and the neck is a body; the narrow part between the lower part of the body and the neck is the isthmus, the uterine isthmus gradually expands along with the gestation period, the lower uterine segment is obviously formed in the near labor, and the obstetrics usually perform the laparotomy and fetus taking at the narrow part. The junction between the upper parts of the two lateral margins of uterus and the fallopian tube is called uterine horn.
The uterine front septum bladder uterine pouch is adjacent to the upper surface of the bladder, the front of the upper part of the cervicovaginal is adjacent to the bottom of the bladder by the vesicovaginal septum, and the cervicovaginal part is adjacent to the urethra by the urethrovaginal septum; the back of the uterus is adjacent to the rectum through the rectouterine pouch and the rectovaginal septum.
At present, the medicine delivery pump body to uterus medicine delivery can't realize the volumetric real-time measurement of uterus to different human different moments to dose based on measurement result decision current confession medicine, thereby can't realize the suitable confession medicine to the uterus when promoting the utilization ratio of uterus treatment medicine.
In order to overcome the defects, the invention builds a dosage control system of the medicine delivery pump body and a corresponding terminal, and can effectively solve the corresponding technical problem.
A drug delivery pump body dose control system is shown according to an embodiment of the present invention comprising:
a drug delivery pump body connected to the volume estimation device for receiving a real-time volume of the uterus and determining a drug delivery dose proportional to the real-time volume to perform a drug delivery of the determined drug delivery dose to the interior of the uterus;
the panoramic capture mechanism is arranged in the uterus of the human body and is used for performing instant image capture on the internal environment of the uterus so as to obtain a corresponding uterus panoramic image;
the guide filtering equipment is connected with the panoramic capturing mechanism and used for executing guide filtering processing on the received image so as to obtain and output a corresponding guide filtering image;
the smooth spatial filtering equipment is connected with the guide filtering equipment and is used for executing smooth spatial filtering processing on the received guide filtering image so as to obtain and output a corresponding smooth spatial filtering image;
the gamma correction device is connected with the smooth space filtering device and is used for executing gamma correction processing on the received smooth space filtering image so as to obtain and output a corresponding gamma correction image;
the uterine body analysis device is connected with the gamma correction device and is used for detecting the pixel value of each pixel of the gamma correction image to determine whether the pixel value is in the brightness threshold range of the distribution of imaging pixel points on the inner wall of the uterus or not, and if the pixel value is in the brightness threshold range, the pixel is determined as a uterine body pixel and the imaging depth of field of the pixel is detected;
the volume estimation device is connected with the uterine body analysis device and is used for calculating the real-time distance between the intrauterine wall entity position corresponding to each uterine body pixel and the panoramic capturing mechanism based on the imaging depth of field of each uterine body pixel of the gamma correction image and the imaging focal length of the panoramic capturing mechanism;
the volume estimation equipment is further used for estimating the real-time volume of the uterus based on the real-time distance between the entity position of each uterine inner wall corresponding to each uterine body pixel of the gamma correction image and the panoramic capture mechanism.
Next, the detailed structure of the drug delivery pump dosage control system of the present invention will be further described.
In the medicine delivery pump body dosage control system:
and if the brightness of the pixel falls outside the brightness threshold range, determining the pixel as a non-uterine body pixel, and not executing the detection processing of the imaging depth of field.
The dosage control system of the medicine delivery pump body can further comprise:
and the ADSL communication equipment is respectively connected with the gamma correction equipment and the uterine body analysis equipment and is used for receiving and reporting various fault codes of the gamma correction equipment or the uterine body analysis equipment.
In the medicine delivery pump body dosage control system:
the gamma correction equipment is internally provided with a first fault self-checking unit used for carrying out self-checking on internal faults of the gamma correction equipment and sending fault codes.
In the medicine delivery pump body dosage control system:
and a second fault self-checking unit is arranged in the uterus body analysis equipment and is used for carrying out self-checking on internal faults of the uterus body analysis equipment and sending fault codes.
In the medicine delivery pump body dosage control system:
the first fault self-checking unit and the second fault self-checking unit are respectively realized by editable logic devices with different models.
In the medicine delivery pump body dosage control system:
the gamma correction equipment is also internally provided with a first electric quantity measuring unit used for measuring the current residual electric quantity of the gamma correction equipment.
In the medicine delivery pump body dosage control system:
the uterine body analysis device is also internally provided with a second electric quantity measuring unit which is used for measuring the current residual electric quantity of the uterine body analysis device;
the first electric quantity measuring unit and the second electric quantity measuring unit share the same quartz oscillation device.
The dosage control system of the medicine delivery pump body can further comprise:
the load detection equipment is used for receiving the utilization rate of the current kernel of the uterine body analysis equipment, and the utilization rate is a percentage;
the data identification equipment is connected with the load detection equipment and is used for sending a load overfill signal when the utilization rate exceeds the limit;
the data discrimination equipment is also used for sending a load sufficiency signal when the received utilization rate is not over limit;
and the GPU chip is connected with the data identification equipment and is used for entering a working mode from a sleep mode when receiving a load overfilling signal.
Meanwhile, in order to overcome the defects, the invention also provides a dosage control terminal of the drug delivery pump body, wherein the terminal comprises: a memory and a processor, the processor coupled to the memory;
wherein the memory is used for storing executable instructions of the processor;
the processor is used for calling the executable instructions in the memory so as to realize the method for determining the drug supply dosage of each uterus based on the real-time volume conditions of different human uteruses by using the drug delivery pump body dosage control system to ensure the corresponding treatment effect.
In addition, ADSL is a technology for providing broadband data transmission service to homes and offices through the existing general telephone line, and it can provide very high data transmission bandwidth wide enough for telecommunication industry to be breathless. The ADSL solution does not require modification of the signal transmission line, it only requires a pair of special MODEMs, one of which is connected to the user's computer and the other of which is installed in the telecommunications center of the telecommunications company, the connections of which are still ordinary telephone lines. The speed of data transmission is indeed much improved after the ADSL scheme is adopted. The transmission speed of the ADSL scheme is about 50 times that of the ISDN scheme and 20 times that of the satellite scheme, and the ADSL does not need to change the line, so that the ADSL is a feasible network acceleration scheme.
ADSL was designed for video on demand at the beginning of its development. With the rapid development of the internet, ADSL has changed over as a technology for accessing the internet at a high speed, so that users feel new and it becomes possible to provide multimedia services on the existing internet. Companies providing telecommunication services are worried that they can configure ASDL equipment according to the user amount very flexibly without investing astronomical digital funds for line replacement, and provide more online services for users.
It should be understood that portions of the present invention may be implemented in hardware, software, firmware, or a combination thereof. In the above embodiments, the various steps or methods may be implemented in software or firmware stored in memory and executed by a suitable instruction execution system. For example, if implemented in hardware, as in another embodiment, any one or combination of the following techniques, which are known in the art, may be used: a discrete logic circuit having a logic gate circuit for implementing a logic function on a data signal, an application specific integrated circuit having an appropriate combinational logic gate circuit, a Programmable Gate Array (PGA), a Field Programmable Gate Array (FPGA), or the like.
It will be understood by those skilled in the art that all or part of the steps carried by the method for implementing the above embodiments may be implemented by hardware related to instructions of a program, which may be stored in a computer readable storage medium, and when the program is executed, the program includes one or a combination of the steps of the method embodiments.
The storage medium mentioned above may be a read-only memory, a magnetic or optical disk, etc. Although embodiments of the present invention have been shown and described above, it is understood that the above embodiments are exemplary and should not be construed as limiting the present invention, and that variations, modifications, substitutions and alterations can be made to the above embodiments by those of ordinary skill in the art within the scope of the present invention.
Claims (10)
1. A drug delivery pump body dose control system, the system comprising:
a drug delivery pump body connected to the volume estimation device for receiving a real-time volume of the uterus and determining a drug delivery dose proportional to the real-time volume to perform a drug delivery of the determined drug delivery dose to the interior of the uterus;
the panoramic capture mechanism is arranged in the uterus of the human body and is used for performing instant image capture on the internal environment of the uterus so as to obtain a corresponding uterus panoramic image;
the guide filtering equipment is connected with the panoramic capturing mechanism and used for executing guide filtering processing on the received image so as to obtain and output a corresponding guide filtering image;
the smooth spatial filtering equipment is connected with the guide filtering equipment and is used for executing smooth spatial filtering processing on the received guide filtering image so as to obtain and output a corresponding smooth spatial filtering image;
the gamma correction device is connected with the smooth space filtering device and is used for executing gamma correction processing on the received smooth space filtering image so as to obtain and output a corresponding gamma correction image;
the uterine body analysis device is connected with the gamma correction device and is used for detecting the pixel value of each pixel of the gamma correction image to determine whether the pixel value is in the brightness threshold range of the distribution of imaging pixel points on the inner wall of the uterus or not, and if the pixel value is in the brightness threshold range, the pixel is determined as a uterine body pixel and the imaging depth of field of the pixel is detected;
the volume estimation device is connected with the uterine body analysis device and is used for calculating the real-time distance between the intrauterine wall entity position corresponding to each uterine body pixel and the panoramic capturing mechanism based on the imaging depth of field of each uterine body pixel of the gamma correction image and the imaging focal length of the panoramic capturing mechanism;
the volume estimation equipment is further used for estimating the real-time volume of the uterus based on the real-time distance between the entity position of each uterine inner wall corresponding to each uterine body pixel of the gamma correction image and the panoramic capture mechanism.
2. The drug delivery pump body dose control system of claim 1, wherein:
and if the brightness of the pixel falls outside the brightness threshold range, determining the pixel as a non-uterine body pixel, and not executing the detection processing of the imaging depth of field.
3. The drug delivery pump body dose control system of claim 2, further comprising:
and the ADSL communication equipment is respectively connected with the gamma correction equipment and the uterine body analysis equipment and is used for receiving and reporting various fault codes of the gamma correction equipment or the uterine body analysis equipment.
4. The drug delivery pump body dose control system of claim 3, wherein:
the gamma correction equipment is internally provided with a first fault self-checking unit used for carrying out self-checking on internal faults of the gamma correction equipment and sending fault codes.
5. The drug delivery pump body dose control system of claim 4, wherein:
and a second fault self-checking unit is arranged in the uterus body analysis equipment and is used for carrying out self-checking on internal faults of the uterus body analysis equipment and sending fault codes.
6. The drug delivery pump body dose control system of claim 5, wherein:
the first fault self-checking unit and the second fault self-checking unit are respectively realized by editable logic devices with different models.
7. The drug delivery pump body dose control system of claim 6, wherein:
the gamma correction equipment is also internally provided with a first electric quantity measuring unit used for measuring the current residual electric quantity of the gamma correction equipment.
8. The drug delivery pump body dose control system of claim 7, wherein:
the uterine body analysis device is also internally provided with a second electric quantity measuring unit which is used for measuring the current residual electric quantity of the uterine body analysis device;
the first electric quantity measuring unit and the second electric quantity measuring unit share the same quartz oscillation device.
9. The drug delivery pump body dose control system of claim 8, further comprising:
the load detection equipment is used for receiving the utilization rate of the current kernel of the uterine body analysis equipment, and the utilization rate is a percentage;
the data identification equipment is connected with the load detection equipment and is used for sending a load overfill signal when the utilization rate exceeds the limit;
the data discrimination equipment is also used for sending a load sufficiency signal when the received utilization rate is not over limit;
and the GPU chip is connected with the data identification equipment and is used for entering a working mode from a sleep mode when receiving a load overfilling signal.
10. A terminal for controlling the dosage of a drug delivery pump body, the terminal comprising: a memory and a processor, the processor coupled to the memory;
the memory for storing executable instructions of the processor;
the processor for invoking executable instructions in the memory for implementing a method for using the drug delivery pump body dose control system according to any one of claims 1-9 to determine a drug delivery dose per uterus based on real-time volume conditions of different human uteri to ensure a corresponding therapeutic effect.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010641079.1A CN113058140A (en) | 2020-07-06 | 2020-07-06 | Dosage control system of medicine delivery pump body and corresponding terminal |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010641079.1A CN113058140A (en) | 2020-07-06 | 2020-07-06 | Dosage control system of medicine delivery pump body and corresponding terminal |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113058140A true CN113058140A (en) | 2021-07-02 |
Family
ID=76558537
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010641079.1A Pending CN113058140A (en) | 2020-07-06 | 2020-07-06 | Dosage control system of medicine delivery pump body and corresponding terminal |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113058140A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113499510A (en) * | 2021-07-14 | 2021-10-15 | 刘银环 | Infusion bag body tube drawing notification platform |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101925382A (en) * | 2008-01-28 | 2010-12-22 | 耶达研究及发展有限公司 | Endoscopic imaging photodynamic therapy system and methods of use |
| CN106562794A (en) * | 2016-10-31 | 2017-04-19 | 重庆康超医疗科技股份有限公司 | Bladder volume measuring device, and implementation method of the same |
| CN106793939A (en) * | 2014-09-17 | 2017-05-31 | 塔里斯生物医药公司 | For the method and system of the diagnostic mapping of bladder |
| CN108939268A (en) * | 2018-05-30 | 2018-12-07 | 上海健康医学院 | Based on image depending on leading through the double target administration monitor control systems of arterial duct |
| CN109847155A (en) * | 2019-01-21 | 2019-06-07 | 孟庆和 | Adaptive disease processing platform |
-
2020
- 2020-07-06 CN CN202010641079.1A patent/CN113058140A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101925382A (en) * | 2008-01-28 | 2010-12-22 | 耶达研究及发展有限公司 | Endoscopic imaging photodynamic therapy system and methods of use |
| CN106793939A (en) * | 2014-09-17 | 2017-05-31 | 塔里斯生物医药公司 | For the method and system of the diagnostic mapping of bladder |
| CN106562794A (en) * | 2016-10-31 | 2017-04-19 | 重庆康超医疗科技股份有限公司 | Bladder volume measuring device, and implementation method of the same |
| CN108939268A (en) * | 2018-05-30 | 2018-12-07 | 上海健康医学院 | Based on image depending on leading through the double target administration monitor control systems of arterial duct |
| CN109847155A (en) * | 2019-01-21 | 2019-06-07 | 孟庆和 | Adaptive disease processing platform |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113499510A (en) * | 2021-07-14 | 2021-10-15 | 刘银环 | Infusion bag body tube drawing notification platform |
| CN113499510B (en) * | 2021-07-14 | 2022-04-22 | 嘉兴市天和制药有限公司 | Infusion bag body tube drawing notification platform |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Vlahos et al. | Myomas and adenomyosis: impact on reproductive outcome | |
| Kagan et al. | How to measure cervical length. | |
| Bij de Vaate et al. | Ultrasound evaluation of the Cesarean scar: relation between a niche and postmenstrual spotting | |
| Kagan et al. | Preterm birth: the value of sonographic measurement of cervical length | |
| CN105943086B (en) | Ultrasonic ovarian follicle somascope and its automatic analysis method | |
| Saravelos et al. | Assessment of the uterus with three-dimensional ultrasound in women undergoing ART | |
| Canteiro et al. | Length of the endometrial cavity as measured by uterine sounding and ultrasonography in women of different parities | |
| Chan et al. | Measuring angle of progression by transperineal ultrasonography to predict successful instrumental and cesarean deliveries during prolonged second stage of labor | |
| Sokolowski et al. | Human uterine wall tension trajectories and the onset of parturition | |
| CN113058140A (en) | Dosage control system of medicine delivery pump body and corresponding terminal | |
| Roach et al. | The normal female pelvis | |
| Liu et al. | Ultrasound diagnosis of intramural pregnancy | |
| Wang et al. | Ectopic pregnancy in uncommon implantation sites: intramural pregnancy and rudimentary horn pregnancy | |
| Wang et al. | Single large cystic adenomyoma of the uterus after cornual pregnancy and curettage | |
| Woraboot et al. | Correlation between lower uterine wall thickness measured by transabdominal ultrasonography and cervical length measured by transvaginal ultrasonography in Thai pregnant women | |
| Kondagari et al. | Sonography gynecology infertility assessment, protocols, and interpretation | |
| Ossman et al. | The role of sildenafil citrate (viagra) suppositories on endometrial response (thickness and mean resistance index of endometrial spiral artery) in cases of unexplained infertility | |
| Kamio et al. | Inguinal hernia containing functioning, rudimentary uterine horn and endometriosis | |
| Fornazari et al. | Functional magnetic resonance imaging for clinical evaluation of uterine contractility | |
| Ji et al. | Application of transperineal ultrasound combined with shear wave elastography in pelvic floor function assessment after hysterectomy | |
| Dasan et al. | A comparative study of saline infused sonohysterography and conventional hysterosalpingography in the evaluation of female infertility | |
| Servaes et al. | The current state of imaging pediatric genitourinary anomalies and abnormalities | |
| Tropeano et al. | Is myomectomy always the best choice for infertile women with symptomatic uterine fibroids? | |
| Fukuda et al. | Mayer‐Rokitansky‐Kustner Hauser syndrome complicated by either uterine leiomyoma or ovarian tumor | |
| Kumar et al. | Successful pregnancy outcome in an untreated case of concomitant transverse complete vaginal septum with unicornuate uterus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210702 |
|
| RJ01 | Rejection of invention patent application after publication |